Cargando…
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
PURPOSE: To assess the diagnostic performance of Whole Body (WB)-MRI in comparison with 18F-Fluorodeoxyglucose-PET/CT (18F-FDG-PET/CT) in lymphoma staging and to assess whether quantitative metabolic parameters from 18F-FDG-PET/CT and Apparent Diffusion Coefficient (ADC) values are related. MATERIAL...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182138/ https://www.ncbi.nlm.nih.gov/pubmed/37145214 http://dx.doi.org/10.1007/s11547-023-01622-9 |
_version_ | 1785041726594875392 |
---|---|
author | Maccioni, Francesca Alfieri, Giulia Assanto, Giovanni Manfredi Mattone, Monica Gentiloni Silveri, Guido Viola, Federica De Maio, Alessandro Frantellizzi, Viviana Di Rocco, Alice De Vincentis, Giuseppe Pulsoni, Alessandro Martelli, Maurizio Catalano, Carlo |
author_facet | Maccioni, Francesca Alfieri, Giulia Assanto, Giovanni Manfredi Mattone, Monica Gentiloni Silveri, Guido Viola, Federica De Maio, Alessandro Frantellizzi, Viviana Di Rocco, Alice De Vincentis, Giuseppe Pulsoni, Alessandro Martelli, Maurizio Catalano, Carlo |
author_sort | Maccioni, Francesca |
collection | PubMed |
description | PURPOSE: To assess the diagnostic performance of Whole Body (WB)-MRI in comparison with 18F-Fluorodeoxyglucose-PET/CT (18F-FDG-PET/CT) in lymphoma staging and to assess whether quantitative metabolic parameters from 18F-FDG-PET/CT and Apparent Diffusion Coefficient (ADC) values are related. MATERIALS AND METHODS: We prospectively enrolled patients with a histologically proven primary nodal lymphoma to undergo 18F-FDG-PET/CT and WB-MRI, both performed within 15 days one from the other, either before starting treatment (baseline) or during treatment (interim). Positive and negative predictive values of WB-MRI for the identification of nodal and extra-nodal disease were measured. The agreement between WB-MRI and 18F-FDG-PET/CT for the identification of lesions and staging was assessed through Cohen's coefficient k and observed agreement. Quantitative parameters of nodal lesions derived from 18F-FDG-PET/CT and WB-MRI (ADC) were measured and the Pearson or Spearman correlation coefficient was used to assess the correlation between them. The specified level of significance was p ≤ 0.05. RESULTS: Among the 91 identified patients, 8 refused to participate and 22 met exclusion criteria, thus images from 61 patients (37 men, mean age 30.7 years) were evaluated. The agreement between 18F-FDG-PET/CT and WB-MRI for the identification of nodal and extra-nodal lesions was 0.95 (95% CI 0.92 to 0.98) and 1.00 (95% CI NA), respectively; for staging it was 1.00 (95% CI NA). A strong negative correlation was found between ADCmean and SUVmean of nodal lesions in patients evaluated at baseline (Spearman coefficient r(s) = − 0.61, p = 0.001). CONCLUSION: WB-MRI has a good diagnostic performance for staging of patients with lymphoma in comparison with 18F-FDG-PET/CT and is a promising technique for the quantitative assessment of disease burden in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11547-023-01622-9. |
format | Online Article Text |
id | pubmed-10182138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-101821382023-05-14 Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas Maccioni, Francesca Alfieri, Giulia Assanto, Giovanni Manfredi Mattone, Monica Gentiloni Silveri, Guido Viola, Federica De Maio, Alessandro Frantellizzi, Viviana Di Rocco, Alice De Vincentis, Giuseppe Pulsoni, Alessandro Martelli, Maurizio Catalano, Carlo Radiol Med Diagnostic Imaging in Oncology PURPOSE: To assess the diagnostic performance of Whole Body (WB)-MRI in comparison with 18F-Fluorodeoxyglucose-PET/CT (18F-FDG-PET/CT) in lymphoma staging and to assess whether quantitative metabolic parameters from 18F-FDG-PET/CT and Apparent Diffusion Coefficient (ADC) values are related. MATERIALS AND METHODS: We prospectively enrolled patients with a histologically proven primary nodal lymphoma to undergo 18F-FDG-PET/CT and WB-MRI, both performed within 15 days one from the other, either before starting treatment (baseline) or during treatment (interim). Positive and negative predictive values of WB-MRI for the identification of nodal and extra-nodal disease were measured. The agreement between WB-MRI and 18F-FDG-PET/CT for the identification of lesions and staging was assessed through Cohen's coefficient k and observed agreement. Quantitative parameters of nodal lesions derived from 18F-FDG-PET/CT and WB-MRI (ADC) were measured and the Pearson or Spearman correlation coefficient was used to assess the correlation between them. The specified level of significance was p ≤ 0.05. RESULTS: Among the 91 identified patients, 8 refused to participate and 22 met exclusion criteria, thus images from 61 patients (37 men, mean age 30.7 years) were evaluated. The agreement between 18F-FDG-PET/CT and WB-MRI for the identification of nodal and extra-nodal lesions was 0.95 (95% CI 0.92 to 0.98) and 1.00 (95% CI NA), respectively; for staging it was 1.00 (95% CI NA). A strong negative correlation was found between ADCmean and SUVmean of nodal lesions in patients evaluated at baseline (Spearman coefficient r(s) = − 0.61, p = 0.001). CONCLUSION: WB-MRI has a good diagnostic performance for staging of patients with lymphoma in comparison with 18F-FDG-PET/CT and is a promising technique for the quantitative assessment of disease burden in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11547-023-01622-9. Springer Milan 2023-05-05 2023 /pmc/articles/PMC10182138/ /pubmed/37145214 http://dx.doi.org/10.1007/s11547-023-01622-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Diagnostic Imaging in Oncology Maccioni, Francesca Alfieri, Giulia Assanto, Giovanni Manfredi Mattone, Monica Gentiloni Silveri, Guido Viola, Federica De Maio, Alessandro Frantellizzi, Viviana Di Rocco, Alice De Vincentis, Giuseppe Pulsoni, Alessandro Martelli, Maurizio Catalano, Carlo Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas |
title | Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas |
title_full | Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas |
title_fullStr | Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas |
title_full_unstemmed | Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas |
title_short | Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas |
title_sort | whole body mri with diffusion weighted imaging versus 18f-fluorodeoxyglucose-pet/ct in the staging of lymphomas |
topic | Diagnostic Imaging in Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182138/ https://www.ncbi.nlm.nih.gov/pubmed/37145214 http://dx.doi.org/10.1007/s11547-023-01622-9 |
work_keys_str_mv | AT maccionifrancesca wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT alfierigiulia wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT assantogiovannimanfredi wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT mattonemonica wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT gentilonisilveriguido wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT violafederica wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT demaioalessandro wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT frantellizziviviana wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT diroccoalice wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT devincentisgiuseppe wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT pulsonialessandro wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT martellimaurizio wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas AT catalanocarlo wholebodymriwithdiffusionweightedimagingversus18ffluorodeoxyglucosepetctinthestagingoflymphomas |